cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLCcardiovascular-1708Research ArticleРЕФЕРАТИВНЫЙ ОБЗОРSUMMARY REVIEWНикорандил в клинической практике кардиологаNicorandil in clinical cardiology practiceРедакционнаястатьяEditorialArticle201220022012111104104Copyright © Редакционная с., 20122012Редакционная с.Editorial a.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/1708
.
.
ReferencesKinoshita M., Sakai K. Pharmacology and Therapeutic Effects of Nicorandil. Cardiovasc. Drugs and Therapy 1990 4: 1075-88.Kinoshita M., Sakai K. Pharmacology and Therapeutic Effects of Nicorandil. Cardiovasc. Drugs and Therapy 1990 4: 1075-88.Meany T.B., Richardson P., Camm A.J., et al. Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris. Am J Cardiology 1989 63: 66-70.Meany T.B., Richardson P., Camm A.J., et al. Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris. Am J Cardiology 1989 63: 66-70.Sakamoto T, Kaikita K, Miyamoto S, et al. Effects of nicorandil on endogenous fibrinolytic capacity in patients with coronary artery disease. Circ J 2004; 68: 232-56.Sakamoto T, Kaikita K, Miyamoto S, et al. Effects of nicorandil on endogenous fibrinolytic capacity in patients with coronary artery disease. Circ J 2004; 68: 232-56.Izumiya Y, Kojima S, Araki S, et al. Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris. Atherosclerosis 2011; 214(2): 415-21.Izumiya Y, Kojima S, Araki S, et al. Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris. Atherosclerosis 2011; 214(2): 415-21.The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 2002; 359: 1269-75.The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 2002; 359: 1269-75.Summary of Product Characteristics last updated on the eMC: 28/04/2011. http://www.medicines.org.uk/emc/medicine/1654/SPCSummary of Product Characteristics last updated on the eMC: 28/04/2011. http://www.medicines.org.uk/emc/medicine/1654/SPCHorinaka S, Yabe A., Yagi H, et al. Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study. Circ.J. 2010; 74(3): 503-9.Horinaka S, Yabe A., Yagi H, et al. Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study. Circ.J. 2010; 74(3): 503-9.Диагностика и лечение стабильной стенокардии. Российские рекомендации (второй пересмотр). ВНОК. Кардиоваскулярная терапия и профилактика 2008; 7(6); Прил. 4: 33.Диагностика и лечение стабильной стенокардии. Российские рекомендации (второй пересмотр). ВНОК. Кардиоваскулярная терапия и профилактика 2008; 7(6); Прил. 4: 33.National Institute for Health and Clinical Excellence. UK. Сlinical guideline 126: Management of stable angina 2011: 14-5.National Institute for Health and Clinical Excellence. UK. Сlinical guideline 126: Management of stable angina 2011: 14-5.Кардиоваскулярная профилактика. Национальные рекомендации. ВНОК. Кардиоваскулярная терапия и профилактика 2011; 10(6); Прил. 2: 57.Кардиоваскулярная профилактика. Национальные рекомендации. ВНОК. Кардиоваскулярная терапия и профилактика 2011; 10(6); Прил. 2: 57.
The authors declare that there are no conflicts of interest present.